Locate Bio
Business Services · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Medicity Thane Rd, Nottingham, Nottingha...Phone Number
+44 1157840041Website
www.locatebio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Locate Bio
LOCATE BIO is an innovative UK MedTech company with industry-leading drug delivery and tissue scaffold capabilities. The company is focused on developing next-generation solutions that address unmet musculoskeletal needs.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Locate Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Locate Bio has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Locate Bio
Funding: Get notified immidiatlly once Locate Bio has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Locate Bio is spiking on competitors!
Earning: See what the market has to say on Locate Bio recently announced quarterly report
Product Launch: Get notified when Locate Bio launches new products
Click to see if Locate Bio had a recent Job posting/layoffs
Locate Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Locate Bio
Find 3 more new buyers
Compare Similar Companies to Locate Bio
Compare insights from companies similar to Locate Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Locate Bio
<$5M
1-10
Private
$27.3M
2001
N/A
Company Profile Activity
Activity Insights
Locate Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Locate Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Locate Bio.
Locate Bio financials insights
Gather financial insights about Locate Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Unspecified
$2.8M
2021
Private Equity
$13.8M
2024
Other Financing Round
$10.7M
Locate Bio Tech Stack
A closer look at the technologies used by Locate Bio
See more technologies
Most Recent Scoops
Funding
Funding
Funding
Funding
Promotion
Executive Move
Promotion
Executive Move
Locate Bio News & Media
Locate Bio’s LDGraft Granted FDA Breakthrough Device Designation
NOTTINGHAM, England--(BUSINESS WIRE)--Locate Bio, a UK-based orthobiologics company, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for LDGraft, currently in development for anterior lumbar interbody spinal fusion (ALIF) procedures at one level from L3-S1 for patients with degenerative disc disease. The FDA Breakthrough Device Program is designed to accelerate patient access to promising technologies that have the potential toLocate Bio Closes £10 Million Funding Round
NOTTINGHAM, England--(BUSINESS WIRE)--Locate Bio, an orthobiologics focused regenerative medicine company, is pleased to announce that it has raised an oversubscribed £10 million of equity investment in a funding round co-led by existing shareholder Mercia Asset Management and new investor BGF. The funding will be used to further advance Locate Bio’s proprietary pipeline of regenerative orthobiologics products towards patients, with key clinical and regulatory milestones expected to catalyse grLocate Bio’s Chondro3 Granted FDA Breakthrough Device Designation
NOTTINGHAM, England--(BUSINESS WIRE)--Locate Bio, an orthobiologics focused regenerative medicine company, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to Chondro3, currently in development as a biomimetic graft for osteochondral lesions. The FDA Breakthrough Device Program is designed to accelerate patient access to promising technologies that have the potential to provide more effective treatment or diagnosis for life-threLocate Bio’s CognitOss Granted FDA Breakthrough Device Designation
NOTTINGHAM, England--(BUSINESS WIRE)--Locate Bio, an orthobiologics focused regenerative medicine company, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to CognitOss, currently in development for the treatment of chronic osteomyelitis. The FDA Breakthrough Device Program is intended to help patients receive more timely access to certain technologies that have the potential to provide more effective treatment or diagnosis for
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Locate Bio
Sign Up For FreeTo access detailed company insights
LOCATE BIO is an innovative UK MedTech company with industry-leading drug delivery and tissue scaffold capabilities. The company is focused on developing next-generation solutions that address unmet musculoskeletal needs.... Read More
